Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer

Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer

Objective Current biomarkers for predicting immunotherapy response in non-small-cell lung cancer (NSCLC) are derived from invasive procedures with limited predictive accuracy. Thus, identifying a non-invasive predictive biomarker would improve patient stratification and precision immunotherapy.Metho...

Full description

Bibliographic Details
Main Authors: Wei Xu, Li Zhang, Ying Wang, Ke Ma, Yunpeng Yang, Yuhui Huang, Peng Fan, Liang Sun, Bo Zhu, Rakesh K. Jain, Zhenhua Liu, Qingzhu Jia, Junhui Wang, Jiya Sun, Liansai Sun, Hongtai Shi, Songbing Qin
Format: Article
Language:English
Published: BMJ Publishing Group 2024-08-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/3/1/e000473.full

Internet

https://bmjoncology.bmj.com/content/3/1/e000473.full

Similar Items